JOHNSON & JOHNSON (JNJ)
JOHNSON & JOHNSON (JNJ)
| Cash Flow | 2026-03-29 | 2025-12-28 | 2025-09-28 | 2025-06-29 |
|---|---|---|---|---|
| Net earnings | 5,235 | 5,116 | 5,152 | 5,537 |
| Depreciation and amortization of property and intangibles | 2,004 | 2,011 | 1,777 | 1,943 |
| Stock based compensation | 300 | 309 | 347 | 410 |
| Asset write-downs | 36 | 81 | 93 | 0 |
| Charges for acquired in-process research and development | NaN | 109 | NaN | NaN |
| (gain) on separation of kenvue | NaN | 0 | NaN | NaN |
| Charges for acquired in-process research and development assets | 1,145 | NaN | 17 | 76 |
| Net loss/(gain) on sale of assets/businesses | -12 | 132 | 57 | -1 |
| Deferred tax provision | 159 | -3,677 | 2,218 | 825 |
| Credit losses and accounts receivable allowances | -8 | 5 | -9 | 7 |
| Increase in accounts receivable | 595 | -391 | -111 | 1,357 |
| Increase in inventories | 431 | 46 | 748 | 510 |
| Decrease in accounts payable and accrued liabilities | -3,920 | 1,266 | 1,997 | 1,240 |
| Decrease/(increase) in other current and non-current assets | -349 | -1,486 | 1,459 | 4,877 |
| Decrease in other current and non-current liabilities | -629 | 499 | -270 | 583 |
| Net cash flows from operating activities | 2,514 | 7,309 | 9,169 | 3,878 |
| Additions to property, plant and equipment | 1,049 | 1,837 | 1,157 | 1,043 |
| Proceeds from the disposal of assets/businesses, net (note 10) | 29 | 312 | 76 | 53 |
| Acquisitions, net of cash acquired | NaN | 3,082 | 1 | 14,458 |
| Acquired in-process research and development/related milestones (note 18) | NaN | 385 | NaN | NaN |
| Acquired in-process research and development assets / related milestones (note 10) | 865 | NaN | 16 | 355 |
| Purchases of investments | 144 | 243 | 246 | 180 |
| Sales of investments | 209 | 219 | 489 | 735 |
| Credit support agreements activity, net | -31 | 209 | 346 | -2,980 |
| Other (including capitalized licenses and milestones) | 54 | 63 | 33 | 36 |
| Net cash used for investing activities | -1,040 | -4,485 | -542 | -18,264 |
| Dividends to shareholders | 3,131 | 3,131 | 3,132 | 3,129 |
| Repurchase of common stock | 4,028 | 1,924 | 1,902 | 0 |
| Proceeds from short-term debt, net | 12,439 | 3,913 | 1,324 | 565 |
| Repayment of short-term debt, net | 3,223 | 1,806 | 5,466 | 2,938 |
| Proceeds from long-term debt, net of issuance costs | 0 | 0 | 0 | 0 |
| Repayment of long-term debt | 2,002 | 2 | 1,001 | 3 |
| Proceeds from the exercise of stock options/employee withholding tax on stock awards, net | 1,172 | 1,587 | 1,274 | 107 |
| Credit support agreements activity, net | -109 | 20 | 25 | -268 |
| Settlement of convertible debt acquired from shockwave | NaN | 0 | 0 | 0 |
| Proceeds of short and long-term debt, net of issuance cost, related to the debt that transferred to kenvue at separation | NaN | 0 | NaN | NaN |
| Proceeds from kenvue initial public offering | NaN | 0 | NaN | NaN |
| Cash transferred to kenvue at separation | NaN | 0 | NaN | NaN |
| Other | -588 | -26 | -49 | 1 |
| Net cash from financing activities | 530 | -1,369 | -8,927 | -5,665 |
| Effect of exchange rate changes on cash and cash equivalents | -25 | 23 | -46 | 154 |
| Increase in cash and cash equivalents | 1,979 | 1,478 | -346 | -19,897 |
| Cash and cash equivalents, beginning of period | 19,709 | 18,231 | 18,577 | 38,474 |
| Cash and cash equivalents, end of period | 21,688 | 19,709 | 18,231 | 18,577 |